Cargando...
Surgery for Pancreatic Cancer after neoadjuvant treatment
Pancreatic ductal adenocarcinoma (PDAC) remains to be a therapeutic challenge as only 15%‐20% of all patients present with resectable tumor stages by the time of diagnosis. In the remaining patients, either local tumor extension or systemic spread are obstacles for a surgical therapy as the only cha...
Guardado en:
| Publicado en: | Ann Gastroenterol Surg |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6236102/ https://ncbi.nlm.nih.gov/pubmed/30460344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12203 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|